Author

Francisco Sanchez-Madrid

Hospital de la Princesa. Universidad Autonoma Madrid - Cited by 59,032 - Inmunologia - biologia celular - bioquimica - comunicacion celular

Biography

Francisco Sanchez-Madrid is working in the Servicio de Inmunología, Hospital Universitario de la Princesa, Spain. Francisco Sanchez-Madrid international experience includes various programs, contributions and participation in different countries for diverse fields of study. Francisco Sanchez-Madrid research interests reflect wide range of publications in various national and international journals.
Title
Cited by
Year
Role of AHR ligands in skin homeostasis and cutaneous inflammation
N Fernández-Gallego, F Sánchez-Madrid, D CibrianCells 10 (11), 3176, 2021202
30
2021
Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial
F Alfonso, JM de la Torre Hernandez, B Ibanez, M Sabate, M Pan, ...Revista Española de Cardiología (English Edition) 75 (6), 515-522, 2022202
21
2022
A differential signature of circulating miRNAs and cytokines between COVID-19 and community-acquired pneumonia uncovers novel physiopathological mechanisms of COVID-19
A differential signature of circulating miRNAs and cytokines between COVID- and community-acquired pneumonia uncovers novel physiopathological mechanisms of COVID-P Martínez-Fleta, P Vera-Tomé, M Jiménez-Fernández, S Requena, ...Frontiers in immunology 12, 815651, 2022202
19
2022
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles
PF Céspedes, A Jainarayanan, L Fernández-Messina, S Valvo, ...Nature Communications 13 (1), 3460, 2022202
10
2022
Single‐reaction multi‐antigen serological test for comprehensive evaluation of SARS‐CoV‐2 patients by flow cytometry
Y Cáceres‐Martell, D Fernández‐Soto, C Campos‐Silva, ...European Journal of Immunology 51 (11), 2633-2640, 2021202
9
2021
Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people …
M Calvet-Mirabent, I Sanchez-Cerrillo, N Martín-Cófreces, ...EBioMedicine 81, 2022202
9
2022
CD4+ T cell immune specificity changes after vaccination in healthy and COVID-19 convalescent subjects
L Esparcia-Pinedo, P Martínez-Fleta, N Ropero, P Vera-Tomé, ...Frontiers in Immunology 12, 75591, 2022202
8
2022
The impact of type 2 immunity and allergic diseases in atherosclerosis
N Fernández‐Gallego, R Castillo‐González, N Méndez‐Barbero, ...Allergy 77 (11), 3249-3266, 2022202
8
2022
Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice
Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD+ T cells and limit CD4+ T‐cell loss in BLT miceM Calvet‐Mirabent, DT Claiborne, M Deruaz, S Tanno, C Serra, ...European journal of immunology 52 (3), 447-461, 2022202
8
2022
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction
R Blanco-Domínguez, H de la Fuente, C Rodríguez, L Martín-Aguado, ...The Journal of Clinical Investigation 132 (21), 2022202
7
2022
Alarming and calming: opposing roles of S100A8/S100A9 dimers and tetramers on monocytes
A Russo, H Schürmann, M Brandt, K Scholz, ALL Matos, D Grill, ...Advanced Science 9 (36), 2201505, 2022202
7
2022
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial
A Cecconi, P Martinez-Vives, A Vera, C Lavilla Olleros, A Barrios, ...Scientific Reports 12 (1), 9208, 2022202
6
2022
Influence of air pollutants on circulating inflammatory cells and microRNA expression in acute myocardial infarction
A Cecconi, G Navarrete, M Garcia-Guimaraes, A Vera, ...Scientific Reports 12 (1), 30, 2022202
5
2022
Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients
EM García-Cuesta, JM Rodríguez-Frade, SR Gardeta, G D’Agostino, ...Proceedings of the National Academy of Sciences 119 (21), e2119483119, 2022202
5
2022
Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: possible role of cTFH cells
Cross-reactive cellular, but not humoral, immunity is detected between OC3 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: possible role of cTFH cellsÁF García-Jiménez, Y Cáceres-Martell, D Fernández-Soto, ...Journal of Leukocyte Biology 112 (2), 339-36, 2022202
4
2022
Antibody drug conjugates
CC MARCHANTE, JMD Correa, AF Solloso, MG García-Ibarrola, ...US Patent 11,22,663, 2022202
4
2022
Development of an effective immune response in adults with down syndrome after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination
L Esparcia-Pinedo, A Yarci-Carrión, G Mateo-Jiménez, N Ropero, ...Clinical Infectious Diseases 76 (), e155-e162, 20220
3
2023
CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4+ T lymphocytes
M Jiménez-Fernández, C Rodríguez-Sinovas, L Cañes, ...Cellular and Molecular Life Sciences 79 (8), 468, 2022202
3
2022
SARS-CoV-2 viremia precedes an IL6 response in severe COVID-19 patients: Results of a longitudinal prospective cohort
SARS-CoV- viremia precedes an IL6 response in severe COVID-19 patients: Results of a longitudinal prospective cohortE Roy-Vallejo, L Cardeñoso, A Triguero-Martínez, M Chicot Llano, ...Frontiers in medicine 9, 855639, 0
2
2022
T cell activation and effector function in the human Jurkat T cell model
C Carrasco-Padilla, O Aguilar-Sopeña, A Gómez-Morón, S Alegre-Gómez, ...Academic Press, 0
2
2022

Referred From: https://scholar.google.com/citations?user=bjiookwAAAAJ&hl=en

Cited by
Citations 59032
h-index 123
i10-index 443
Recommended Journals
Open Access Journals